Bingli Yan
Ph.D Degree in Organic Synthesis from University of Missouri-St. Louis
Post-doctoral research in Organic Synthesis at University of Pittsburgh
Senior QA Specialist at Millipore-Sigma
Principal Scientist at Pfizer, stability strategist for various modalities/projects including late phase Vaccines, GTx and early phase mAbs. A member of stability council within Pfizer.
Appearances
DateJune 28, 2023Cell and Gene Therapy programs are progressing from early academic settings to commercial manufacturing at increasingly faster pace and in greater numbers. These therapies are complex, difficult to manufacture in large quantities, and involve many bespoke technologies to make, test and release…Session Chairs
Speakers
